CIAM
VTYX

Caitong International Asset Management’s Ventyx Biosciences VTYX Stock Holding History

Caitong International Asset Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,771
Closed -$5.49K – 2534
2025
Q1 		$5.49K Buy
4,771
+4,375
+1,105% +$7.51K ﹤0.01% 999
2024
Q4 		$867 Buy
+396
New +$897 ﹤0.01% 1359

Other funds holding VTYX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Caitong International Asset Management's VTYX Position: Q2 2025 in Review

Caitong International Asset Management sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 4,771 shares — an estimated $5.49K sold.

Caitong International Asset Management first reported a position in VTYX in Q4 2024 and held it in 2 quarters. The position peaked at $5.49K in Q1 2025. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • Caitong International Asset Management reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 4,771 Ventyx Biosciences shares in Q2 2025, an estimated $5.49K.
  • Caitong International Asset Management first reported a position in Ventyx Biosciences in Q4 2024 and held it in 2 quarters.
  • Caitong International Asset Management's Ventyx Biosciences position peaked at $5.49K in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Caitong International Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.